valine has been researched along with fluorodeoxyglucose f18 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Kirikae, M | 1 |
| Almkvist, O; Bogdanovic, N; Långström, B; Nordberg, A; Schöll, M; Viitanen, M; Wall, A | 1 |
| Ahmed, R; Fox, NC; Guerreiro, R; Guven, G; Hardy, J; Rohrer, JD; Rossor, MN | 1 |
| Axer, H; Grimm, A; Karvouniari, P; Rupprecht, S; Schultze, T; Schwab, M; Witte, OW; Zinke, J | 1 |
| Amoura, Z; Arnaud, L; Barete, S; Benameur, N; Besnard, S; Charlotte, F; Cluzel, P; Cohen-Aubart, F; Donadieu, J; Drier, A; Emile, JF; Graffin, B; Granel, B; Grenier, PA; Haroche, J; Hervier, B; Idbaih, A; Lifermann, F; Maksud, P; Ory, JP; Tolédano, D | 1 |
| Bae, SK; Ha, TK; Jung, SJ; Kim, TH; Lee, SM; Park, JS; Urm, SH; Yoon, M | 1 |
| Abdel-Wahab, O; Arcila, ME; Baselga, J; Blay, JY; Chau, I; Diamond, EL; Durham, B; Elez, E; Erinjeri, JP; Hyman, DM; Lacouture, M; Lockhart, AC; Makrutzki, M; Martínez-Valle, F; Pitcher, B; Puzanov, I; Raje, NS; Riehl, T; Subbiah, V; Torrisi, J; Ulaner, G; Wolf, J | 1 |
| Beck, MCH; Booij, J; Ceccarini, J; Frank, M; Heinzel, A; Hernaus, D; Kasanova, Z; Mohammadkhani-Shali, S; Mottaghy, F; Myin-Germeys, I; van Amelsvoort, T; van Duin, EDA; Winz, O | 1 |
| Goh, HJ; Goh, JP; Govindharajulu, P; Henry, CJ; Leow, MK; Michael, N; Sadananthan, SA; Sun, L; Velan, SS; Verma, S | 1 |
3 trial(s) available for valine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
Reproducible and sustained efficacy of targeted therapy with vemurafenib in patients with BRAF(V600E)-mutated Erdheim-Chester disease.
Topics: Adult; Aged; Erdheim-Chester Disease; Female; Fluorodeoxyglucose F18; Glutamic Acid; Humans; Indoles; Male; Middle Aged; Molecular Targeted Therapy; Mutation; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Skin; Sulfonamides; Treatment Outcome; Valine; Vemurafenib | 2015 |
Vemurafenib for BRAF V600-Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study.
Topics: Aged; Amino Acid Substitution; Erdheim-Chester Disease; Female; Fluorodeoxyglucose F18; Histiocytosis, Langerhans-Cell; Humans; Male; Middle Aged; Mutation, Missense; Positron Emission Tomography Computed Tomography; Prognosis; Proto-Oncogene Proteins B-raf; Survival Analysis; Treatment Outcome; Valine; Vemurafenib | 2018 |
Brown adipose tissues mediate the metabolism of branched chain amino acids during the transitioning from hyperthyroidism to euthyroidism (TRIBUTE).
Topics: Adipose Tissue, Brown; Amino Acids, Branched-Chain; Fluorodeoxyglucose F18; Humans; Hyperthyroidism; Insulin; Insulin Resistance; Isoleucine; Leucine; Valine | 2022 |
6 other study(ies) available for valine and fluorodeoxyglucose f18
| Article | Year |
|---|---|
[Assessment of local cerebral glucose utilization and protein synthesis in a rat brain tumor model. Simultaneous measurement by quantitative double-racer autoradiography].
Topics: Animals; Autoradiography; Brain; Brain Neoplasms; Carbon Radioisotopes; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Protein Biosynthesis; Rats; Rats, Inbred Strains; Valine | 1988 |
Time course of glucose metabolism in relation to cognitive performance and postmortem neuropathology in Met146Val PSEN1 mutation carriers.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognition Disorders; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status Schedule; Methionine; Middle Aged; Mutation; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Postmortem Changes; Presenilin-1; Statistics as Topic; Time Factors; Valine | 2011 |
A novel A781V mutation in the CSF1R gene causes hereditary diffuse leucoencephalopathy with axonal spheroids.
Topics: Aged; Alanine; Family Health; Female; Fluorodeoxyglucose F18; Genetic Testing; Humans; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Positron-Emission Tomography; Receptor, Macrophage Colony-Stimulating Factor; Valine | 2013 |
Does the clinical phenotype of fatal familial insomnia depend on PRNP codon 129 methionine-valine polymorphism?
Topics: Adult; Brain; Codon; Diagnosis, Differential; Fatal Outcome; Female; Fluorodeoxyglucose F18; Humans; Insomnia, Fatal Familial; Methionine; Phenotype; Polymorphism, Genetic; Polysomnography; Positron-Emission Tomography; Prion Proteins; Prions; Radiopharmaceuticals; Tomography, X-Ray Computed; Valine; Young Adult | 2013 |
Relationships between transporter expression and the status of BRAF V600E mutation and F-18 FDG uptake in papillary thyroid carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Carcinoma; Carcinoma, Papillary; Female; Fluorodeoxyglucose F18; Glucose Transporter Type 1; Glucose Transporter Type 3; Glutamic Acid; Humans; Immunohistochemistry; Male; Middle Aged; Mutation, Missense; Positron-Emission Tomography; Proto-Oncogene Proteins B-raf; Retrospective Studies; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, Emission-Computed; Valine; Young Adult | 2016 |
Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome.
Topics: Adult; Benzamides; Brain Mapping; Catechol O-Methyltransferase; Corpus Striatum; DiGeorge Syndrome; Dopamine; Dopamine D2 Receptor Antagonists; Female; Fluorodeoxyglucose F18; Humans; Intelligence Tests; Learning Disabilities; Magnetic Resonance Imaging; Male; Methionine; Middle Aged; Mutation; Positron-Emission Tomography; Reinforcement, Psychology; Task Performance and Analysis; Valine | 2018 |